Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
about
Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sitesStructure and function of the two tandem WW domains of the pre-mRNA splicing factor FBP21 (formin-binding protein 21)The Molecular Basis for Substrate Specificity of the Nuclear NIPP1:PP1 HoloenzymeUnderstanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory codePlasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survivalDendritic geometry shapes neuronal cAMP signalling to the nucleusNMR studies of the C-terminus of alpha4 reveal possible mechanism of its interaction with MID1 and protein phosphatase 2AEnsemble modeling of protein disordered states: experimental restraint contributions and validation.Identification of a Plasmodium falciparum inhibitor-2 motif involved in the binding and regulation activity of protein phosphatase type 1Molecular basis for an ancient partnership between prolyl isomerase Pin1 and phosphatase inhibitor-2Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators.Flexibility in the PP1:spinophilin holoenzymeMolecular investigations of the structure and function of the protein phosphatase 1-spinophilin-inhibitor 2 heterotrimeric complexAnchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein.The extended PP1 toolkit: designed to create specificity.Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.DARPP-32, Jack of All Trades… Master of Which?Structural basis for protein phosphatase 1 regulation and specificityFolding of Intrinsically Disordered Protein Phosphatase 1 Regulatory Proteins.DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neuronsRegulation of protein phosphatase 1 by intrinsically disordered proteinsBiophysical characterization of intrinsically disordered proteins.Strategies to optimize protein expression in E. coli.Novel strategies for drug discovery based on Intrinsically Disordered Proteins (IDPs)Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition.The evolutionary strata of DARPP-32 tail implicates hierarchical functional expansion in higher vertebrates.Strategies to make protein serine/threonine (PP1, calcineurin) and tyrosine phosphatases (PTP1B) druggable: achieving specificity by targeting substrate and regulatory protein interaction sites.t-Darpp is an elongated monomer that binds calcium and is phosphorylated by cyclin-dependent kinases 1 and 5.Structural signature of the MYPT1-PP1 interaction.Structured States of Disordered Proteins from Genomic SequencesDevelopment of phosphatase inhibitor-1 peptides acting as indirect activators of phosphatase 1.Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approaches.
P2860
Q24304144-B85147C5-68C6-4488-B897-B13794704E45Q24313388-2F32B7AE-1731-443E-AE6E-91B6A9BCABE6Q27671832-4B034F9A-C7FA-4090-A1E5-AFC64C0F1249Q27681976-7F443013-1F6C-476A-9C72-885211C65A5EQ27973484-BDD57A50-B9BC-4D2C-B403-BCFA91E25940Q28388999-2F0C2965-C1B9-443C-A857-C97254732A65Q28478425-D334B61D-1C2C-4625-9D21-816E34CD51DBQ30010207-F96BEF1E-8834-485B-BA1F-DB17A625E4B6Q30038955-AA71A41E-F273-432A-A62B-E84CF73916CCQ30414196-E1DA4F13-9B06-4720-937E-8A675A0097FAQ34116108-5E00412C-3E79-4B64-86BC-F8FA96B0CFD3Q34474276-16E79EA2-D2AC-406B-ADC2-2384009F4FD4Q34579434-9C5FC809-4900-4D77-887F-CE5CF15077E2Q34875111-990B46B6-EAF8-41F1-B6D7-AB58B03B6CA7Q35092072-50906AA9-7447-42C8-8503-BC6257F84A1FQ35182543-BCD6AB8C-20F8-4AED-990F-F9949E143042Q35201971-88163ADE-A9B2-40E0-8B2E-3B641728A1C4Q35954007-EEB59AB5-6263-46B6-BA0E-27CC0C1CBA31Q36132363-D0408653-5084-4052-85B5-C0D8868D3179Q36361852-B8292C5A-9DF5-4755-9F47-F51D1A40CB4EQ36413937-21450365-13CA-47E6-9A8B-BA129E98CB47Q37375367-84F147AF-34D7-4DBE-AC4B-8E34D3E83DCBQ37785042-3ACB5162-7DA8-4491-AC86-DEBDEB357B4AQ37891686-4E5CFDDC-0F3B-4556-920D-5469E9A005E9Q38700387-E1A968AD-30F0-4C19-809C-32AB27B9D635Q39189145-D9F4B2D7-6A9F-4AFF-B5E9-7A07853C1BF0Q41514506-EB811862-5B3F-43E8-8838-83260E8E9663Q41627665-26441A8C-2D7E-4BC7-B06A-8A38050AEF81Q41652019-BA5A3C46-1DD1-43EB-9C19-6BA2D2D0875BQ41698527-70E486B0-56E2-4EEA-BE0D-B19E108254F6Q43570941-EC7EC76F-93C3-4DEA-B49D-09108CEE30CFQ44874960-D6C7B13C-CFA2-4498-90A5-3B757292B478
P2860
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@en
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@nl
type
label
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@en
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@nl
prefLabel
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@en
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@nl
P2860
P356
P1433
P1476
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
@en
P2093
Barbara Dancheck
Wolfgang Peti
P2860
P304
12346-12356
P356
10.1021/BI801308Y
P407
P577
2008-11-01T00:00:00Z